Bdpazo (Pazopanib) Tablet

Description

Description

This page contains brief details about the drug pazopanib, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Pazopanib is an antiangiogenic agent which was approved for its medical use on 19th October 2009.

Mechanism of Action of Pazopanib

Pazopanib is a biological agent that acts as targeted drug therapy in cancer treatment. It is an anticancer medication that belongs to the category of tyrosine kinase inhibitors. It interferes with the growth of blood vessels inside the cancer cells by acting against a protein called Vascular Endothelial Growth Factors (VEGF) to shrink cancer cells, ultimately stopping their growth and multiplication.

Uses of Pazopanib

Pazopanib has been developed to treat a type of kidney cancer (Renal cell carcinoma) and soft tissue cancer after disease progression and inadequate response to other anticancer therapies.

Pazopanib Dosage available

Pazopanib is available in the form of tablets in the doses 200mg and 400mg. The usual recommended dose is 800mg once a day without food. You can take this medicine an hour before food or two hours after your meals. For patients with moderate liver impairment, the usual recommended dose is 200mg once daily. Your healthcare provider will adjust the dosing according to how well your body tolerates this medication.